American Society of Health-System Pharmacists Research and Education
Public records show a registered, tax-exempt organization in good standing.
What it says it does
OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.
- Income
- $3.6 million
- Spending
- $3.2 million
- Spent on programs
- 65%
- Reserves
- 16.4 months of spending
- Largest source of income
- donations and private grants, 48%
- Employees
- 0
- Volunteers
- 100
- Highest pay
- $1.2 million, president
Source: Form 990 for the year ending May 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 93 out of 100. Higher than 78% of charities in its peer group (religion, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 16.4 months of spending.
Debt
20 of 20It owes 5% of what it owns.
Living within its means
15 of 15Income exceeded spending by 9% of income.
Income trend
15 of 15Income rose 20% on the year before.
Spending floor
8 of 1565% of spending went to programs and raising each dollar of donations cost 45 cents.
Source: Form 990 for the year ending May 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100. Higher than 85% of charities in its peer group (religion, $1m to $10m).
Independent board
25 of 2510 of 15 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending May 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (3)
- $1.3 million spent. EXCELLENCE IN PHARMACY PRACTICE AND LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY. ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATED HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON THE IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE SUPPORTED THE 2024 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. AWARDEES RECEIVE A PLAQUE AND PARTICIPATE IN SHORT INTERVIEWS AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION (ASHP MIDYEAR). EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES WERE RECOGNIZED IN FIVE (5) DIFFERENT CATEGORIES IN 2024. AWARDEES RECEIVE AN HONORARIUM, PLAQUE, PARTICIPATE IN SHORT INTERVIEWS AND PODCASTS, AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR MEETING. MIDYEAR TRAVEL AWARD: THE MIDYEAR TRAVEL AWARD, ORIGINALLY CREATED AS A COLLABORATION BETWEEN THE ASHP FOUNDATION AND #PHARMGRADWISHLIST, AWARDED 32 PHARMD CANDIDATES WITH A $500 TRAVEL STIPEND, REGISTRATION TO THE ASHP MIDYEAR MEETING, AND A ONE-YEAR ASHP MEMBERSHIP. THERE WERE 260 APPLICATIONS RECEIVED FOR THE AWARD IN FY25. THE PROGRAM WAS PARTIALLY FUNDED VIA $25,000 DONATIONS EACH FROM MARVIN SAMSON AND APEXUS, ALONG WITH INDIVIDUAL DONATIONS. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY25, THE ASHP FOUNDATION ENGAGED WITH SELECTED RECIPIENTS OF THE PHARMACY STUDENT SCHOLARSHIP. THE SCHOLARSHIP WAS AWARDED IN SPRING 2025 (FY24) THROUGH FOUR US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) SCHOOLS OF PHARMACY FOR THE 2024-2025 ACADEMIC YEAR. NO SCHOLARSHIPS WERE AWARDED THROUGH THIS PROGRAM IN FY25. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. A COHORT OF EIGHT PHARMACY RESIDENTS IN PGY2 PROGRAMS WERE SELECTED TO COMPLETE THE PROGRAM WITH THEIR PRECEPTOR. THE PREVIOUS COHORT COMPLETED THE EXPERIENTIAL PORTION OF THE PROGRAM THROUGHOUT FY25. THE APPLICATION FOR A NEW CYCLE OPENED IN FY25, WITH THE COHORT SELECTED IN FY26. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE COHORT PARTICIPATED IN A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. THE COHORT WILL HAVE A NETWORKING DINNER AND FINALIZE THEIR PROJECT IN FY26. PHARMACY RESIDENCY EXPANSION GRANT: IN FY25, SUPPORTED BY AN EDUCATIONAL DONATION FROM MERCK & CO., INC., RAHWAY, NJ, USA, THE ASHP FOUNDATION AWARDED A TOTAL OF $75,000 DOLLARS IN GRANTS TO THREE (3) PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: GABRIELLA MIGNOSA AND EMMA VAN REYSEN FROM THE UNIVERSITY OF RHODE ISLAND COLLEGE OF PHARMACY COMPETED FOR THE 2024 ASHP NATIONAL CLINICAL SKILLS COMPETITION, AND WON THE COMPETITION IN DECEMBER 2024, DURING THE ASHP MIDYEAR CLINICAL MEETING IN NEW ORLEANS, LA. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING FOR 19 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.EXCELLENCE IN RESIDENCY: FUNDED THROUGH THE DANIEL M. ASHBY FUND FOR EXCELLENCE IN PHARMACY RESIDENCY TRAINING, THE FOUNDATION CONTRACTED WITH UNIVERSITY OF GEORGIA (UGA) AND ASHP'S ACCREDITATION SERVICES DIVISION ON A GRANT TO UGA AND SUBSEQUENT RESEARCH PROJECT TO STUDY RESIDENTS' PROGRAM EXPERIENCES AND COMPLETION. PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A DONATION FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY25 CONSISTED OF 104 PARTICIPANTS, W
- $835,278 spent. INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP: THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $10,000 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM AWARDED TO PH.D. STUDENTS WHOSE RESEARCH PROJECTS FOCUS ON IMPROVING HEALTH OUTCOMES IN HOSPITALS, HEALTH SYSTEMS, AND AMBULATORY CARE CLINICS. RADIO FREQUENCY IDENTIFICATION (RFID) INITIATIVE: IN ALIGNMENT WITH THE ASHP INNOVATION CENTER AND THROUGH SUPPORT FROM FRESENIUS KABI, THE ASHP FOUNDATION CONTINUED TO WORK ON THE NEXT PHASES OF THE RFID INITIATIVE. IN SEPTEMBER AND NOVEMBER 2024, VIRTUAL ENGAGEMENT SESSIONS WERE CONDUCTED WITH FACILITATION AND BREAKOUT SESSIONS. THE SESSIONS HIGHLIGHTED IMPLEMENTED RFID USE-CASE, RECOMMENDATIONS, AND OUTCOMES. ADDITIONALLY, FUNDING FOR A NEW RESEARCH PROJECT HAS BEEN SECURED. PHARMACY LEADERSHIP SCHOLARS:WITH CORPORATE SUPPORT FROM CHIESI, A NEW CYCLE OF THE PHARMACY LEADERSHIP SCHOLARS PROGRAM WAS LAUNCHED. THE RESEARCH GRANT PROGRAM PROVIDES FUNDING FOR PROJECTS FOCUSED ON ACCESS TO CARE, CONDUCTED BY EARLY-STAGE PHARMACISTS. IN ADDITION TO PROVIDING UP TO $10,000 IN GRANT FUNDING PER RECIPIENT, THE PROGRAM'S GOAL IS TO ENHANCE THE LEADERSHIP AND RESEARCH SKILLS OF RECIPIENTS AND TO PROVIDE A NETWORK OF PHARMACISTS POSITIONED TO LEAD. FOUR PROJECTS WERE FUNDED IN FY25 AND GRANTEES PARTICIPATED IN FOUR MODULES, LED BY FACULTY, AND ENGAGED IN LIVE DISCUSSION CALLS WITH FACULTY AND A COACH. ADDITIONALLY, THE APPLICATION PROCESS FOR A NEW CYCLE WAS COMPLETED AND GRANTEES SELECTED TO PARTICIPATE IN THE PROGRAM IN FY26. COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS:CREATED IN PARTNERSHIP BY THE ASHP FOUNDATION AND THE AMERICAN NURSES FOUNDATION, THIS GRANT PROGRAM AIMS TO STIMULATE PATIENT-CENTERED INTERPROFESSIONAL HEALTH SERVICES RESEARCH THAT DEMONSTRATES MEANINGFUL OUTCOMES AND PROVIDES FUNDING OF $75,000. THE FINAL PAYMENT FOR THE PREVIOUS CYCLE'S GRANTEE AND FUNDING FOR A NEW GRANTEE WAS REMITTED IN FY25. SPECIALTY PHARMACY GRANT FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE:ADMINISTERED BY THE FOUNDATION IN CLOSE CONSULTATION WITH THE ASHP SECTION OF SPECIALTY PHARMACY PRACTITIONERS, AND SUPPORTED BY OMNICELL, INC., THE GRANT FUNDED PROJECTS FOCUSED ON SPECIALTY PHARMACY FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE. THE GRANTS WERE AWARDED IN FY24. THE COHORT ENGAGED WITH A COACH AND FACULTY ON LIVE CALLS TO DISCUSS TOPICS RELATED TO RESEARCH, DISSEMINATING OUTCOMES, AND IMPLEMENTATION IN FY25. THE GRANTEES PRESENTED AT A SESSION AT THE 2025 MIDYEAR CLINICAL MEETING AND EXHIBITION IN FY26. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM: THE PHARMACY RESIDENT RESEARCH GRANT SUPPORTS QUALITY HEALTH SERVICE RESEARCH FOCUSED ON PRACTICE ADVANCEMENT CONDUCTED BY RESIDENTS IN ASHP-ACCREDITED PHARMACY RESIDENCY PROGRAMS. THIS GRANT PROGRAM IS FUNDED THROUGH THE ALMQUIST ENDOWMENT. THE EXTERNAL REVIEW PANEL RECOMMENDED FUNDING UP TO $5,000 EACH FOR SIX (6) GRANT PROJECTS. ONE GRANT WAS PARTIALLY FUNDED THROUGH THE DWIGHT R. TOUSIGNAUT MEMORIAL FUND. OPTIMIZING TECHNOLOGY SOLUTIONS INNOVATION GRANT: CREATED IN PARTNERSHIP WITH THE ASHP INNOVATION CENTER AND SUPPORTED BY A GENEROUS DONATION FROM OMNICELL, INC. TO THE ASHP FOUNDATION, THIS PROGRAM FUNDS PROJECTS THAT DEMONSTRATE THE IMPACT OF OPTIMIZING HEALTH INFORMATION TECHNOLOGY AND DIGITAL TRANSFORMATION THAT ENHANCE SAFE AND EFFECTIVE USE OF MEDICATIONS. TWO GRANTEES WERE AWARDED $30,000 IN FY25. RESEARCH ADVISORY COUNCIL:IN FY25, DR. RASHID MOSAVIN SERVED AS THE CHAIR AND DR. RANDALL KNOEBEL SERVED AS THE VICE CHAIR OF THE RESEARCH ADVISORY COUNCIL (RAC) FOR THE TERM. THREE MEMBERS WERE REAPPOINTED AND TWO MEMBERS COMPLETED THEIR SERVICE IN MAY 2024. NO NEW MEMBERS WERE APPOINTED FOR THIS TERM. THE RAC CONVENED VIRTUALLY THROUGHOUT THE YEAR AND LED A VIRTUAL NETWORKING SESSION IN SUMMER 2024. THE RAC PARTICIPATED IN AN IN-PERSON MEETING AT ASHP HEADQUARTERS IN SEPTEMBER 2024, TO ALIGN WITH ASHP'S POLICY WEEK ACTIVITIES. THERE WAS ONE RESEARCH PODCAST HIGHLIGHTING THE SUSTAINED CONTRIBUTIONS RECIPIENT LAUNCHED AND A RESEARCH ROUNDTABLE WAS HELD DURING THE ASHP MIDYEAR CLINICAL MEETING IN DECEMBER 2024. PHARMACY FORECAST REPORT 2025: THE 2025 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2025 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 60,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2024 AND PREVIEWED DURING AN EDUCATIONAL SESSION AT THE 2024 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. PHARMACY IMPACT RESEARCH:THE ASHP FOUNDATION PROVIDED A GRANT TO ASHP TO SUPPORT THE CONSENSUS PROCESS AND DISSEMINATION OF RESULTS FOR THE MEASURE FOR IMPACT: DEMONSTRATING VALUE OF PHARMACY SERVICES PROJECT. USING VALIDATED CONSENSUS BUILDING METHODOLOGY, THE INITIATIVE'S GOAL IS TO ENGAGE SUBJECT MATTER EXPERTS FROM A VARIETY OF PRACTICE SETTINGS TO IDENTIFY STANDARD MEASURES FOR PHARMACY PRACTICE. MEASURES WILL BE SELECTED FOR THE FOLLOWING DOMAINS: (1) MEDICATION USE AND SAFETY, (2) PATIENT CARE AND QUALITY, (3) OPERATIONS, AUTOMATION AND TECHNOLOGY, (4) WORKFORCE AND PEOPLE, AND (5) FINANCIAL MANAGEMENT. PART OF THE GRANT WAS PROVIDED IN FY25 WITH THE REMAINING FUNDS SCHEDULED TO BE REMITTED IN FY26 WITH WORK CONTINUING THROUGHOUT THE YEAR.
- THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.
Source: Form 990 for the year ending May 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending May 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since December 1999.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.